• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年痴呆症患者中 SARS-CoV-2 感染的发病率和结局:一项基于人群的队列研究。

Incidence and Outcomes of SARS-CoV-2 Infection in Older Adults Living with Dementia: A Population-Based Cohort Study.

机构信息

Department of Epidemiology, Lazio Regional Health Service, Rome, Italy.

出版信息

J Alzheimers Dis. 2022;89(2):681-693. doi: 10.3233/JAD-220369.

DOI:10.3233/JAD-220369
PMID:35912744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9535569/
Abstract

BACKGROUND

The identification of risk factors for SARS-CoV-2 infection and mortality in patients with dementia is a key aspect to support clinical decisions and public health interventions.

OBJECTIVE

To assess the incidence of SARS-CoV-2 infection and COVID-19 related death in a cohort of patients with dementia residing in the Lazio region and to investigate predicting factors for both infection and mortality.

METHODS

This population-based study used information from administrative databases and the SARS-CoV-2 infection surveillance system. Patients with dementia (age ≥65) were enrolled as of December 31, 2019 and followed-up until February 28, 2021. Cumulative risk of infection and death within 60 days of infection onset, and age-standardized incidence (SIR) and mortality (SMR) ratios were calculated. Logistic regression models were applied to identify factors associated with infection and mortality.

RESULTS

Among 37,729 dementia patients, 2,548 had a diagnosis of SARS-CoV-2 infection. The crude risk of infection was 6.7%. An increase in risk of infection was observed both in women (SIR 1.72; 95% CI 1.64-1.80) and men (SIR 1.43; 95% CI 1.33-1.54). Pneumonia, cerebrovascular and blood diseases, femur fracture, anxiety, antipsychotic and antithrombotic use were associated with an increased risk of infection. The crude risk of death was 31.0%, the SMRs 2.32 (95% CI 2.05-2.65) for men, and 2.82 (95% CI 2.55-3.11) for women. Factors associated with mortality included: male gender, age ≥85, symptoms at the diagnosis, antipsychotic and systemic antibiotics treatment.

CONCLUSION

These findings emphasize the need of close and tailored monitoring of dementia patients to reduce the impact of COVID-19 on this fragile population.

摘要

背景

确定痴呆症患者感染 SARS-CoV-2 病毒和死亡的风险因素是支持临床决策和公共卫生干预的关键方面。

目的

评估居住在拉齐奥地区的痴呆症患者队列中 SARS-CoV-2 感染和 COVID-19 相关死亡的发生率,并研究感染和死亡率的预测因素。

方法

本基于人群的研究使用了行政数据库和 SARS-CoV-2 感染监测系统的信息。自 2019 年 12 月 31 日起招募年龄≥65 岁的痴呆症患者,并随访至 2021 年 2 月 28 日。计算感染后 60 天内感染和死亡的累积风险,并计算标准化发病率(SIR)和死亡率(SMR)比值。应用逻辑回归模型确定与感染和死亡相关的因素。

结果

在 37729 例痴呆症患者中,有 2548 例被诊断为 SARS-CoV-2 感染。感染的粗风险为 6.7%。女性(SIR 1.72;95%CI 1.64-1.80)和男性(SIR 1.43;95%CI 1.33-1.54)的感染风险均增加。肺炎、脑血管和血液疾病、股骨骨折、焦虑、抗精神病药和抗血栓药物的使用与感染风险增加相关。死亡的粗风险为 31.0%,男性 SMRs 为 2.32(95%CI 2.05-2.65),女性为 2.82(95%CI 2.55-3.11)。与死亡率相关的因素包括:男性、年龄≥85 岁、诊断时出现症状、抗精神病药和全身抗生素治疗。

结论

这些发现强调需要密切监测痴呆症患者,以减少 COVID-19 对这一脆弱人群的影响。

相似文献

1
Incidence and Outcomes of SARS-CoV-2 Infection in Older Adults Living with Dementia: A Population-Based Cohort Study.老年痴呆症患者中 SARS-CoV-2 感染的发病率和结局:一项基于人群的队列研究。
J Alzheimers Dis. 2022;89(2):681-693. doi: 10.3233/JAD-220369.
2
Antipsychotic drug prescribing and mortality in people with dementia before and during the COVID-19 pandemic: a retrospective cohort study in Wales, UK.抗精神病药物处方与新冠大流行前后痴呆患者的死亡率:英国威尔士的一项回顾性队列研究。
Lancet Healthy Longev. 2023 Aug;4(8):e421-e430. doi: 10.1016/S2666-7568(23)00105-8.
3
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益(CoV-Surv 研究):一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.
4
Risk factors associated with COVID-19 infection and mortality in nursing homes.与养老院中 COVID-19 感染和死亡相关的风险因素。
Aten Primaria. 2022 Oct;54(10):102463. doi: 10.1016/j.aprim.2022.102463. Epub 2022 Sep 6.
5
Risk Factors for Longer-Term Mortality in Discharged Patients with Dementia and SARS-CoV-2 Infection: A Matched Case-Control Study.痴呆症合并新型冠状病毒肺炎感染出院患者长期死亡的危险因素:一项匹配病例对照研究。
J Alzheimers Dis. 2023;92(1):295-309. doi: 10.3233/JAD-221093.
6
[Impact of the COVID-19 epidemic in Friuli Venezia Giulia Region (Northern Italy): assessment of factors associated with the risk of death by competing risks analysis].[新冠疫情对弗留利-威尼斯朱利亚大区(意大利北部)的影响:通过竞争风险分析评估与死亡风险相关的因素]
Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):128-135. doi: 10.19191/EP20.5-6.S2.111.
7
Association of Psychiatric Disorders With Incidence of SARS-CoV-2 Breakthrough Infection Among Vaccinated Adults.接种疫苗的成年人中精神疾病与SARS-CoV-2突破性感染发生率的关联
JAMA Netw Open. 2022 Apr 1;5(4):e227287. doi: 10.1001/jamanetworkopen.2022.7287.
8
Risk of COVID-19 diagnosis and death in patients with mental illness: a cohort study.精神疾病患者 COVID-19 诊断和死亡风险:一项队列研究。
Epidemiol Psychiatr Sci. 2021 Oct 14;30:e68. doi: 10.1017/S2045796021000597.
9
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.一项评估 SARS-CoV-2 疫苗(灭活,Vero 细胞)有效性和安全性的随机、双盲、安慰剂对照 III 期临床试验:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1.
10
Association of BNT162b2 Vaccine Third Dose Receipt With Incidence of SARS-CoV-2 Infection, COVID-19-Related Hospitalization, and Death Among Residents of Long-term Care Facilities, August to October 2021.2021 年 8 月至 10 月,BNT162b2 疫苗第三剂接种与长期护理机构居民 SARS-CoV-2 感染、COVID-19 相关住院和死亡的相关性。
JAMA Netw Open. 2022 Jul 1;5(7):e2219940. doi: 10.1001/jamanetworkopen.2022.19940.

引用本文的文献

1
Impact of COVID-19 on functional, cognitive, neuropsychiatric, and health-related outcomes in patients with dementia: A systematic review.新型冠状病毒肺炎对痴呆患者功能、认知、神经精神及健康相关结局的影响:一项系统评价
eNeurologicalSci. 2024 Nov 21;38:100539. doi: 10.1016/j.ensci.2024.100539. eCollection 2025 Mar.
2
Outpatient Antipsychotic Use and Severe COVID-19: Avoiding the Impact of Age in a Real-World Data Study.门诊抗精神病药使用与严重 COVID-19:在真实世界数据研究中避免年龄的影响。
Int J Neuropsychopharmacol. 2024 Apr 1;27(4). doi: 10.1093/ijnp/pyae020.
3
A new national survey of centers for cognitive disorders and dementias in Italy.

本文引用的文献

1
Mortality among Care Home Residents in England during the first and second waves of the COVID-19 pandemic: an observational study of 4.3 million adults over the age of 65.英国新冠疫情第一波和第二波期间养老院居民的死亡率:对430万65岁以上成年人的观察性研究
Lancet Reg Health Eur. 2022 Jan 10;14:100295. doi: 10.1016/j.lanepe.2021.100295. eCollection 2022 Mar.
2
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019.2019 年全球痴呆症患病率估计及 2050 年预测患病率:2019 年全球疾病负担研究分析。
Lancet Public Health. 2022 Feb;7(2):e105-e125. doi: 10.1016/S2468-2667(21)00249-8. Epub 2022 Jan 6.
3
意大利认知障碍和痴呆症中心的一项新全国性调查。
Neurol Sci. 2024 Feb;45(2):525-538. doi: 10.1007/s10072-023-06958-8. Epub 2023 Aug 18.
4
Prevalence and economic burden of dementia in the Arab world.阿拉伯世界痴呆症的患病率及经济负担。
BJPsych Open. 2023 Jul 13;9(4):e126. doi: 10.1192/bjo.2023.517.
5
Alzheimer's disease and COVID-19: Interactions, intrinsic linkages, and the role of immunoinflammatory responses in this process.阿尔茨海默病与 COVID-19:相互作用、内在联系,以及免疫炎症反应在这一过程中的作用。
Front Immunol. 2023 Feb 9;14:1120495. doi: 10.3389/fimmu.2023.1120495. eCollection 2023.
6
Dementia and psychotropic medications are associated with significantly higher mortality in geriatric patients hospitalized with COVID-19: data from the StockholmGeroCovid project.痴呆症和精神药物与老年 COVID-19 住院患者的死亡率显著升高相关:来自 StockholmGeroCovid 项目的数据。
Alzheimers Res Ther. 2023 Jan 6;15(1):5. doi: 10.1186/s13195-022-01154-w.
7
Frequency and burden of neurological manifestations upon hospital presentation in COVID-19 patients: Findings from a large Brazilian cohort.COVID-19 患者住院时神经系统表现的频率和负担:来自巴西大队列的研究结果。
J Neurol Sci. 2022 Dec 15;443:120485. doi: 10.1016/j.jns.2022.120485. Epub 2022 Nov 9.
Mortality Risk within 14 Days after Coronavirus Disease 2019 Diagnosis in Dementia Patients: A Nationwide Analysis.
新冠肺炎确诊后 14 天内痴呆患者的死亡风险:一项全国性分析。
Dement Geriatr Cogn Disord. 2021;50(5):425-436. doi: 10.1159/000519466. Epub 2021 Dec 2.
4
COVID-19 Case Fatality and Alzheimer's Disease.COVID-19 病死率与阿尔茨海默病
J Alzheimers Dis. 2021;84(4):1447-1452. doi: 10.3233/JAD-215161.
5
The effects of Alzheimer's and Parkinson's disease on 28-day mortality of COVID-19.阿尔茨海默病和帕金森病对 COVID-19 28 天死亡率的影响。
Rev Neurol (Paris). 2022 Jan-Feb;178(1-2):129-136. doi: 10.1016/j.neurol.2021.08.002. Epub 2021 Sep 13.
6
Dementia and Parkinson's Disease: Risk Factors for 30-Day Mortality in Nursing Home Residents with COVID-19.痴呆和帕金森病:COVID-19 养老院居民 30 天死亡率的危险因素。
J Alzheimers Dis. 2021;84(3):1173-1181. doi: 10.3233/JAD-210319.
7
Sex Differences in Immunity to Viral Infections.病毒感染中的性别差异。
Front Immunol. 2021 Aug 31;12:720952. doi: 10.3389/fimmu.2021.720952. eCollection 2021.
8
Immunity, Sex Hormones, and Environmental Factors as Determinants of COVID-19 Disparity in Women.女性 COVID-19 差异的决定因素:免疫、性激素和环境因素。
Front Immunol. 2021 Aug 18;12:680845. doi: 10.3389/fimmu.2021.680845. eCollection 2021.
9
Preexisting Mental Disorders Increase the Risk of COVID-19 Infection and Associated Mortality.既往精神障碍增加 COVID-19 感染及相关死亡风险。
Front Public Health. 2021 Aug 9;9:684112. doi: 10.3389/fpubh.2021.684112. eCollection 2021.
10
Neurological comorbidities and COVID-19-related case fatality: A cohort study.神经合并症与 COVID-19 相关病死率:一项队列研究。
J Neurol Sci. 2021 Sep 15;428:117610. doi: 10.1016/j.jns.2021.117610. Epub 2021 Aug 5.